Literature DB >> 33588764

Causal inference concepts applied to three observational studies in the context of vaccine development: from theory to practice.

Emilia Gvozdenović1,2, Lucio Malvisi3, Elisa Cinconze3, Stijn Vansteelandt4,5, Phoebe Nakanwagi1, Emmanuel Aris1, Dominique Rosillon6.   

Abstract

BACKGROUND: Randomized controlled trials are considered the gold standard to evaluate causal associations, whereas assessing causality in observational studies is challenging.
METHODS: We applied Hill's Criteria, counterfactual reasoning, and causal diagrams to evaluate a potentially causal relationship between an exposure and outcome in three published observational studies: a) one burden of disease cohort study to determine the association between type 2 diabetes and herpes zoster, b) one post-authorization safety cohort study to assess the effect of AS04-HPV-16/18 vaccine on the risk of autoimmune diseases, and c) one matched case-control study to evaluate the effectiveness of a rotavirus vaccine in preventing hospitalization for rotavirus gastroenteritis.
RESULTS: Among the 9 Hill's criteria, 8 (Strength, Consistency, Specificity, Temporality, Plausibility, Coherence, Analogy, Experiment) were considered as met for study c, 3 (Temporality, Plausibility, Coherence) for study a, and 2 (Temporary, Plausibility) for study b. For counterfactual reasoning criteria, exchangeability, the most critical assumption, could not be tested. Using these tools, we concluded that causality was very unlikely in study b, unlikely in study a, and very likely in study c. Directed acyclic graphs provided complementary visual structures that identified confounding bias and helped determine the most accurate design and analysis to assess causality.
CONCLUSIONS: Based on our assessment we found causal Hill's criteria and counterfactual thinking valuable in determining some level of certainty about causality in observational studies. Application of causal inference frameworks should be considered in designing and interpreting observational studies.

Entities:  

Keywords:  Causal diagrams; Causal inference; Counterfactual reasoning; Hill’s criteria; Observational studies; Vaccine development

Mesh:

Substances:

Year:  2021        PMID: 33588764      PMCID: PMC7882866          DOI: 10.1186/s12874-021-01220-1

Source DB:  PubMed          Journal:  BMC Med Res Methodol        ISSN: 1471-2288            Impact factor:   4.615


  48 in total

1.  THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION?

Authors:  A B HILL
Journal:  Proc R Soc Med       Date:  1965-05

2.  Bias in matched case-control studies: DAGs are not enough.

Authors:  Neil Pearce
Journal:  Eur J Epidemiol       Date:  2018-01-25       Impact factor: 8.082

Review 3.  The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria.

Authors:  M C Dickerson; J Johnston; T E Delea; A White; E Andrews
Journal:  Sex Transm Dis       Date:  1996 Sep-Oct       Impact factor: 2.830

Review 4.  Assessing the safety of adjuvanted vaccines.

Authors:  S Sohail Ahmed; Stanley A Plotkin; Steven Black; Robert L Coffman
Journal:  Sci Transl Med       Date:  2011-07-27       Impact factor: 17.956

5.  Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine: up to 8.4 years of follow-up.

Authors:  Cecilia M Roteli-Martins; Paulo Naud; Paola De Borba; Julio C Teixeira; Newton S De Carvalho; Toufik Zahaf; Nervo Sanchez; Brecht Geeraerts; Dominique Descamps
Journal:  Hum Vaccin Immunother       Date:  2012-02-13       Impact factor: 3.452

6.  Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.

Authors:  Julie A Boom; Jacqueline E Tate; Leila C Sahni; Marcia A Rench; Jennifer J Hull; Jon R Gentsch; Manish M Patel; Carol J Baker; Umesh D Parashar
Journal:  Pediatrics       Date:  2010-01-18       Impact factor: 7.124

7.  Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials.

Authors:  Dominique Descamps; Karin Hardt; Bart Spiessens; Patricia Izurieta; Thomas Verstraeten; Thomas Breuer; Gary Dubin
Journal:  Hum Vaccin       Date:  2009-05-20

8.  Data Resource Profile: Clinical Practice Research Datalink (CPRD).

Authors:  Emily Herrett; Arlene M Gallagher; Krishnan Bhaskaran; Harriet Forbes; Rohini Mathur; Tjeerd van Staa; Liam Smeeth
Journal:  Int J Epidemiol       Date:  2015-06-06       Impact factor: 7.196

9.  Risk of herpes zoster among diabetics: a matched cohort study in a US insurance claim database before introduction of vaccination, 1997-2006.

Authors:  A P Guignard; M Greenberg; C Lu; D Rosillon; V Vannappagari
Journal:  Infection       Date:  2014-06-29       Impact factor: 3.553

Review 10.  Causality Assessment of Olfactory and Gustatory Dysfunction Associated with Intranasal Fluticasone Propionate: Application of the Bradford Hill Criteria.

Authors:  Chandrashekhar S Muganurmath; Amy L Curry; Andrew H Schindzielorz
Journal:  Adv Ther       Date:  2018-02-02       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.